SOFTX logo

SoftOx Solutions AS Stock Price

OB:SOFTX Community·NOK 145.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

SOFTX Share Price Performance

NOK 0.061
0.04 (281.25%)
NOK 0.061
0.04 (281.25%)
Price NOK 0.061

SOFTX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

SoftOx Solutions AS Key Details

NOK 13.6m

Revenue

NOK 0

Cost of Revenue

NOK 13.6m

Gross Profit

NOK 16.6m

Other Expenses

-NOK 3.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 25, 2026
-0.0013
100.00%
-22.06%
0%
View Full Analysis

About SOFTX

Founded
2012
Employees
2
CEO
Thomas Bjarnsholt
WebsiteView website
soft-ox.com

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. SoftOx Solutions AS was founded in 2012 and is headquartered in Fornebu, Norway.

Recent SOFTX News & Updates

Recent updates

No updates